Henri Termeer General Information

Description

Mr. Henri Termeer Board Member of Aura Biosciences. He serves as Lead Director at Verastem. He also serves as Chief Executive Officer at Deknatel-Snowden Pencer. He is a Co-Founder of Arrakis Therapeutic. He served as the Board Member at Medical Simulation. Prior to June 2011, he had served as president and a director of Genzyme Corporation, a leading global public biotechnology company, since October 1983, as chief executive officer since 1985 and as chairman of the board since May 1988. He was co-chairman of the transition committee following the acquisition of Genzyme by Sanofi in April 2011 and resigned from Genzyme in June 2011 following the completion of the initial phase of the integration plan. He is also chairman emeritus of the New England Healthcare Institute, a nonprofit, applied research health policy organization that he was instrumental in founding. He served as a director of Allergan from 2014 to 2015 and a director of the Pharmaceutical Research and Manufacturers of America from 1997 to 2011. He is also a former chairman of the Federal Reserve Bank of Boston's board of directors and served as board member of ABIOMED Inc., a public medical device company; Moderna Therapeutics, a private biotechnology company; and ProQR Therapeutics, a Netherlands-based biotechnology company focused on the development of drugs to treat genetic disorders. He is a Board Member of Massachusetts Institute of Technology Corporation and serves on its executive committee. He is a Director of Massachusetts General Hospital, a board member of Partners HealthCare and a member of the board of fellows of Harvard Medical School.